The global healthcare sector, which accounts for 10% of global GDP, continues to face major challenges, including heightened governmental scrutiny, pricing pressures and competition, and investor demand for growth and profitability. To address these challenges, healthcare companies consolidate, restructure, form joint ventures and rely on in-licensing opportunities.
Shearman & Sterling’s global healthcare clients include biopharmaceutical companies; large, specialty and generic pharmaceutical companies; medical device manufacturers and healthcare services providers. With our deep understanding of the healthcare industry, our lawyers are able to assist clients in achieving their business objectives whether through M&A, restructuring, financings or dispute resolutions. Our approach is to form a partnership with our clients to produce strategic, tangible results.
Healthcare Industry Podcast
Attracting a Strong Board:
The Challenges for Healthcare
Partner Doreen Lilienfeld discusses the industry’s unique aspects, shares her insights on the impact of ISS and Glass Lewis’s 2017 recommendations on board composition and provides valuable advice on how a board can make itself attractive to top candidates. Listen >